
Jose M. Mesa
Examiner (ID: 7325, Phone: (571)270-1706 , Office: P/2484 )
| Most Active Art Unit | 2484 |
| Art Unit(s) | 2484 |
| Total Applications | 760 |
| Issued Applications | 560 |
| Pending Applications | 54 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5534483
[patent_doc_number] => 20090234271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'COMPOSITION COMPRISING siRNA-POLYCATION COMPLEX FOR IONTOPHORESIS'
[patent_app_type] => utility
[patent_app_number] => 12/392883
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8884
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12392883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/392883 | COMPOSITION COMPRISING siRNA-POLYCATION COMPLEX FOR IONTOPHORESIS | Feb 24, 2009 | Abandoned |
Array
(
[id] => 5509096
[patent_doc_number] => 20090082303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'DRUG FOR PREVENTING AND TREATING ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/274736
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28457
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082303.pdf
[firstpage_image] =>[orig_patent_app_number] => 12274736
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/274736 | DRUG FOR PREVENTING AND TREATING ATHEROSCLEROSIS | Nov 19, 2008 | Abandoned |
Array
(
[id] => 5441800
[patent_doc_number] => 20090093439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)'
[patent_app_type] => utility
[patent_app_number] => 12/205558
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 74925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12205558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/205558 | RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Sep 4, 2008 | Abandoned |
Array
(
[id] => 5446885
[patent_doc_number] => 20090048111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'RNA INTERFERENCE USING A UNIVERSAL TARGET'
[patent_app_type] => utility
[patent_app_number] => 12/205327
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 30186
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048111.pdf
[firstpage_image] =>[orig_patent_app_number] => 12205327
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/205327 | RNA INTERFERENCE USING A UNIVERSAL TARGET | Sep 4, 2008 | Abandoned |
Array
(
[id] => 4792688
[patent_doc_number] => 20080293662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/171291
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18103
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293662.pdf
[firstpage_image] =>[orig_patent_app_number] => 12171291
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/171291 | RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF | Jul 9, 2008 | Abandoned |
Array
(
[id] => 5509348
[patent_doc_number] => 20090082555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/157383
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 46400
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157383
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157383 | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics | Jun 8, 2008 | Abandoned |
Array
(
[id] => 5297099
[patent_doc_number] => 20090012025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Methods and Compositions for Treatment of Sepsis'
[patent_app_type] => utility
[patent_app_number] => 12/029412
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 15851
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12029412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/029412 | Methods and Compositions for Treatment of Sepsis | Feb 10, 2008 | Abandoned |
Array
(
[id] => 4727260
[patent_doc_number] => 20080206803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Metabolic genes and related methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 12/012781
[patent_app_country] => US
[patent_app_date] => 2008-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10530
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12012781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/012781 | Metabolic genes and related methods and compositions | Feb 4, 2008 | Abandoned |
Array
(
[id] => 5337901
[patent_doc_number] => 20090054365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/020923
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13012
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054365.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020923
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020923 | RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION | Jan 27, 2008 | Abandoned |
Array
(
[id] => 4740567
[patent_doc_number] => 20080234220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Methods and compositions for reducing viral genome amounts in a small target stem cell'
[patent_app_type] => utility
[patent_app_number] => 11/953705
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8826
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953705
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953705 | Methods and compositions for reducing viral genome amounts in a target cell | Dec 9, 2007 | Issued |
Array
(
[id] => 4728005
[patent_doc_number] => 20080207549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 11/948790
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 31537
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11948790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/948790 | GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA | Nov 29, 2007 | Abandoned |
Array
(
[id] => 4676855
[patent_doc_number] => 20080214486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/946335
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12089
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11946335
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/946335 | RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS | Nov 27, 2007 | Abandoned |
Array
(
[id] => 4808141
[patent_doc_number] => 20080171719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/946395
[patent_app_country] => US
[patent_app_date] => 2007-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11976
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11946395
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/946395 | RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS | Nov 27, 2007 | Abandoned |
Array
(
[id] => 4954969
[patent_doc_number] => 20080187993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/940987
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12276
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187993.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940987 | METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS | Nov 14, 2007 | Abandoned |
Array
(
[id] => 217286
[patent_doc_number] => 07612196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)'
[patent_app_type] => utility
[patent_app_number] => 11/978900
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 34300
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/612/07612196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978900 | siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) | Oct 29, 2007 | Issued |
Array
(
[id] => 4693231
[patent_doc_number] => 20080086002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'siRNA targeting secreted frizzled-related protein 1 (sFRP1)'
[patent_app_type] => utility
[patent_app_number] => 11/978125
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 34319
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20080086002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978125 | siRNA targeting secreted frizzled-related protein 1 (sFRP1) | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4922756
[patent_doc_number] => 20080071073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'siRNA targeting ubiquitin ligases'
[patent_app_type] => utility
[patent_app_number] => 11/977675
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 33922
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20080071073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11977675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/977675 | siRNA targeting ubiquitin ligases | Oct 24, 2007 | Abandoned |
Array
(
[id] => 5392165
[patent_doc_number] => 20090209478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE'
[patent_app_type] => utility
[patent_app_number] => 11/859288
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16768
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11859288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/859288 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE | Sep 20, 2007 | Abandoned |
Array
(
[id] => 4839385
[patent_doc_number] => 20080279870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'ALK protein tyrosine kinase, cells and methods embodying and using same'
[patent_app_type] => utility
[patent_app_number] => 11/901487
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23097
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901487 | ALK protein tyrosine kinase, cells and methods embodying and using same | Sep 17, 2007 | Issued |
Array
(
[id] => 4693228
[patent_doc_number] => 20080085999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS'
[patent_app_type] => utility
[patent_app_number] => 11/830647
[patent_app_country] => US
[patent_app_date] => 2007-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8883
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085999.pdf
[firstpage_image] =>[orig_patent_app_number] => 11830647
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/830647 | MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS | Jul 29, 2007 | Abandoned |